Influence of anaemia in patients with head and neck cancer receiving adjuvant postoperative radiotherapy in the Grampian region

Clinical Oncology

Volumn 16, Issue 1, 2004, Pages 63-70

  Macdonald, A Graham ^a,b   Hurman, D C ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b Vancouver Cancer Centre   (Canada)

Author keywords

Anaemia; Haemoglobin; Head and neck cancer; Postoperative radiotherapy

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HOST; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIVARIATE ANALYSIS; OROPHARYNX CANCER; OUTCOMES RESEARCH; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION; UNITED KINGDOM;

EID: 1042268931     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2003.09.009     Document Type: Article

References (37)

1. Information and Statistics Division data, Cancer Services Agency for NHS Scotland, at www.show.scot.nhs.uklisdlcancer.htm.
2. Feldman M, Fletcher GH. Analysis of the parameters relating to failures above the clavicles in patients treated by postoperative irradiation for squamous cell carcinomas of the oral cavity or oropharynx. Int J Radiat Oncol Biol Phys 1982;8:27-30.
3. Vikram B, Strong EW, Shah JP, et al. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 1984;6:720-723.
4. Vikram B, Strong EW, Shah JP, et al. Failure in the neck following multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984;6:724-729.
5. Kramer S, Gelber RD, Snow JB, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:19-30.
6. Canaday DJ, Regine WF, Mohiuddin M, et al. Significance of pre-treatment hemoglobin level in patients with T1 glottic cancer. Radiat Oncol Investig 1999;7:42-48.
7. Dische S. Radiotherapy and anaemia: the clinical experience. Radiother Oncol 1991;20(suppl 1):35-40.
8. Grant DG, Hussain A, Hurman D. Pre-treatment anaemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy. J Laryngol Otol 1999;113:829-833.
9. Overgaard J. The influence of haemoglobin concentrations on the response to radiotherapy. Scand J Clin Lab Invest 1988;48:49-53.
10. Molls M, Stadler P, Becker A, et al. Relevance of oxygen in radiation therapy: mechanisms of action, correlation to low haemoglobin levels. Strahlenther Onkol 1998;174:13-16.
11. Dunst J, Pigorsch S, Hansgen G, et al. A. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anaemia stimulate angiogenesis? Strahlenther Onkol 1999;175:93-96.
12. Bush RS, Jenkin RD, Allt WE, et al. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 1978; 37(suppl):302-306.
13. Fyles AW, Milosevic M, Pintilie M, et al. Anaemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 2000;57:13-19.
14. Fletcher GH. Clinical dose-response curve of subclinical aggregates of epithelial cells and its practical application in the management of human cancers. In: Friedman M, ed. Biological and clinical basis of radiosensitivity. Springfield, IL: Thomas CC, 1974:485-501.
15. Fletcher GH. In: Fletcher GH, ed. Textbook of Radiotherapy, 2nd edn. Philadelphia: Lea & Febiger, 1973.
16. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for post-operative radiation therapy of head and neck cancer: first report of a prospective randomised trial. Int J Radiat Oncol Biol Phys 1993;26:3-11.
17. Frommhold H, Guttenberger R, Henke M. The impact of blood haemoglobin content on the outcome of radiotherapy. The Freiburg Experience. Strahlenther Oncol 1998;174(suppl 4):31-34.
18. Guttenberger R, Lutterbach J, Roth A, et al. Haemoglobin levels predict local regional control after post-operative radiotherapy for advanced head and neck cancer. Eur J Cancer 1997;33(suppl): 102-103; poster 452.
19. Sobin LH, Wittekind C, eds. UICC: TNM Classification of Malignant Tumours, 5th edn. New York, Wiley, 1997.
20. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
21. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
22. Cox D. Regression models for life tables. J R Stat Soc 1972; 34:187-220.
23. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995;310:170.
24. Pfreundner L, Willner J, Marx A, et al. The influence of the radicality of resection and dose of post-operative radiation therapy on local control and survival in carcinomas of the upper aero-digestive tract. Int J Radiat Oncol Biol Phys 2000;47:1287-1297.
25. Dunst J, Molls M. Incidence and impact of anaemia in radiation oncology. In: Nowrousian MR, ed. Recombinant human erythropoietin (rhEPO) in clinical oncology. Scientific and clinical aspects of anaemia in cancer. Wien: Springer-Verlag, 2002:102.
26. Rosenthal DI, Liu L, Lee JH, et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck 2002; 24:115-126.
27. Looser KG, Shah JP, Strong EW. The significance of 'positive' margins in surgically resected epidermoid carcinomas. Head Neck Surg 1978;1:107-111.
28. Amdur RJ, Parsons JT, Mendenhall WM, et al. Post-operative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 1989;16:25-36.
29. Mendenhall WM, Parsons JT, Million RR. Elective lower neck irradiation: 5000 cGy/25 fractions versus 4050 cGy/15 fractions. Int J Radiat Oncol Biol Phys 1988;15:439-440.
30. Overgaard J, Hansen HS, Overgaard M, et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 1998;46:135-146.
31. Tarnawski R, Skladowski K, Maciejewski B. Prognostic value of hemoglobin concentration in radiotherapy for cancer of supraglottic larynx. Int J Radiat Oncol Biol Phys 1997;38:1007-1011.
32. Overgaard J. Modification of hypoxia-from Gottwald Schwarz to nicotinamide: have we learned the lesson? In: Kogelnik HD, ed. Progress in Radio-Oncology 1995;5:469-475.
33. Overgaard J. Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors. Oncol Res 1994;6:509-518.
34. Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 1999;91:1616-1634.
35. Barrett-Lee PJ, Bailey NP, O'Brien ME, et al. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer 2000;82:93-97.
36. Cascinu S, Fedeli A, Del Ferro E, et al. Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo. J Clin Oncol 1994;12: 1058-1062.
37. Case DC Jr., Bukowski RM, Carey RW, et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 1993;85:801-806.